 | • レポートコード：QYR9ST03592 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、脳疾患の世界市場について調査・分析し、脳疾患の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（脳がん、アルツハイマー病、アルコール依存症、健忘症、てんかん、髄膜炎、その他）、用途別（病院薬局、オンライン薬局、薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の脳疾患市場動向 ・主要企業別マーケットシェア ・脳疾患の種類別市場規模2014-2019 （脳がん、アルツハイマー病、アルコール依存症、健忘症、てんかん、髄膜炎、その他） ・脳疾患の用途別市場規模2014-2019 （病院薬局、オンライン薬局、薬局） ・脳疾患の北米市場：主要企業・種類別/用途別市場規模 ・脳疾患のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・脳疾患の中国市場：主要企業・種類別/用途別市場規模 ・脳疾患の日本国内市場：主要企業・種類別/用途別市場規模 ・脳疾患の東南アジア市場：主要企業・種類別/用途別市場規模 ・脳疾患のインド市場：主要企業・種類別/用途別市場規模 ・脳疾患の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Pfizer、Eli Lilly、F. Hoffmann La Roche、GE Healthcare、Janssen Pharmaceuticals、Abbvie、AC Immune、Allergan、Merck、Novartis、AstraZeneca） ・脳疾患の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Brain diseases a part of central nervous system diseases, is a condition where the brain structure or functions alter. The brain diseases include conditions or disabilities that affect the brain. Mostly brain disorders occur due to traumatic injury, genetic or other diseases, while a small number of brain diseases occur due to environmental factors. The major concerned brain disease are caused due to brain deterioration which may lead to neurodegenerative diseases such as Alzheimer’s, Huntington’s disease, and others. The mental disorders or mental illness occurrence is also related to the brain diseases, which include depression, anxiety, bipolar disorders, and others. The etiology of brain disease is not specific. It can occur to anyone and the risk factors of brain diseases differ in accordance to the different types of brain diseases. The sign and symptoms also differ for every brain diseases. Some of the most common symptoms include headache, memory loss, tremors, increased reflexes, slurred speech, paralysis, and inability to concentrate among others. Moreover, the treatment of brain diseases range from surgery to rehabilitation to medications; depending upon the brain disease the patient is affected by. The brain diseases are progressive which may affect the daily life of patients and hence should be immediately treated upon their diagnosis or detection.The incidence and prevalence of brain diseases and disorders increase with age. The growing baby booming population is the major factor driving the brain disease market, globally. Rising prevalence of brain diseases is expected to boost the growth of the market. Due lack of effective treatment for some brain diseases such as brain cancer, they are a huge demand for medicinal treatment. Because of this reason, key market players are intensively focusing on R&D to develop a safe and effective treatment for brain diseases. All these factors act as driver for burgeoning growth of the brain disease market. However, adverse effects associated with the medications of brain diseases is anticipated to hinder the market growth.
In 2018, the global Brain Disease market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Brain Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Brain Disease development in United States, Europe and China.
The key players covered in this study
Pfizer
Eli Lilly
F. Hoffmann La Roche
GE Healthcare
Janssen Pharmaceuticals
Abbvie
AC Immune
Allergan
Merck
Novartis
AstraZeneca
Market segment by Type, the product can be split into
Brain Cancer
Alzheimer Disease
Alcoholism
Amnesia
Epilepsy
Meningitis
Others
Market segment by Application, split into
Hospitals Pharmacy
Online Pharmacy
Pharmacy
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Brain Disease status, future forecast, growth opportunity, key market and key players.
To present the Brain Disease development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Brain Disease are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Brain Disease Market Size Growth Rate by Type (2014-2025)
1.4.2 Brain Cancer
1.4.3 Alzheimer Disease
1.4.4 Alcoholism
1.4.5 Amnesia
1.4.6 Epilepsy
1.4.7 Meningitis
1.4.8 Others
1.5 Market by Application
1.5.1 Global Brain Disease Market Share by Application (2014-2025)
1.5.2 Hospitals Pharmacy
1.5.3 Online Pharmacy
1.5.4 Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Brain Disease Market Size
2.2 Brain Disease Growth Trends by Regions
2.2.1 Brain Disease Market Size by Regions (2014-2025)
2.2.2 Brain Disease Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Brain Disease Market Size by Manufacturers
3.1.1 Global Brain Disease Revenue by Manufacturers (2014-2019)
3.1.2 Global Brain Disease Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Brain Disease Market Concentration Ratio (CR5 and HHI)
3.2 Brain Disease Key Players Head office and Area Served
3.3 Key Players Brain Disease Product/Solution/Service
3.4 Date of Enter into Brain Disease Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Brain Disease Market Size by Type (2014-2019)
4.2 Global Brain Disease Market Size by Application (2014-2019)
5 United States
5.1 United States Brain Disease Market Size (2014-2019)
5.2 Brain Disease Key Players in United States
5.3 United States Brain Disease Market Size by Type
5.4 United States Brain Disease Market Size by Application
6 Europe
6.1 Europe Brain Disease Market Size (2014-2019)
6.2 Brain Disease Key Players in Europe
6.3 Europe Brain Disease Market Size by Type
6.4 Europe Brain Disease Market Size by Application
7 China
7.1 China Brain Disease Market Size (2014-2019)
7.2 Brain Disease Key Players in China
7.3 China Brain Disease Market Size by Type
7.4 China Brain Disease Market Size by Application
8 Japan
8.1 Japan Brain Disease Market Size (2014-2019)
8.2 Brain Disease Key Players in Japan
8.3 Japan Brain Disease Market Size by Type
8.4 Japan Brain Disease Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Brain Disease Market Size (2014-2019)
9.2 Brain Disease Key Players in Southeast Asia
9.3 Southeast Asia Brain Disease Market Size by Type
9.4 Southeast Asia Brain Disease Market Size by Application
10 India
10.1 India Brain Disease Market Size (2014-2019)
10.2 Brain Disease Key Players in India
10.3 India Brain Disease Market Size by Type
10.4 India Brain Disease Market Size by Application
11 Central & South America
11.1 Central & South America Brain Disease Market Size (2014-2019)
11.2 Brain Disease Key Players in Central & South America
11.3 Central & South America Brain Disease Market Size by Type
11.4 Central & South America Brain Disease Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Brain Disease Introduction
12.1.4 Pfizer Revenue in Brain Disease Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Brain Disease Introduction
12.2.4 Eli Lilly Revenue in Brain Disease Business (2014-2019)
12.2.5 Eli Lilly Recent Development
12.3 F. Hoffmann La Roche
12.3.1 F. Hoffmann La Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Brain Disease Introduction
12.3.4 F. Hoffmann La Roche Revenue in Brain Disease Business (2014-2019)
12.3.5 F. Hoffmann La Roche Recent Development
12.4 GE Healthcare
12.4.1 GE Healthcare Company Details
12.4.2 Company Description and Business Overview
12.4.3 Brain Disease Introduction
12.4.4 GE Healthcare Revenue in Brain Disease Business (2014-2019)
12.4.5 GE Healthcare Recent Development
12.5 Janssen Pharmaceuticals
12.5.1 Janssen Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Brain Disease Introduction
12.5.4 Janssen Pharmaceuticals Revenue in Brain Disease Business (2014-2019)
12.5.5 Janssen Pharmaceuticals Recent Development
12.6 Abbvie
12.6.1 Abbvie Company Details
12.6.2 Company Description and Business Overview
12.6.3 Brain Disease Introduction
12.6.4 Abbvie Revenue in Brain Disease Business (2014-2019)
12.6.5 Abbvie Recent Development
12.7 AC Immune
12.7.1 AC Immune Company Details
12.7.2 Company Description and Business Overview
12.7.3 Brain Disease Introduction
12.7.4 AC Immune Revenue in Brain Disease Business (2014-2019)
12.7.5 AC Immune Recent Development
12.8 Allergan
12.8.1 Allergan Company Details
12.8.2 Company Description and Business Overview
12.8.3 Brain Disease Introduction
12.8.4 Allergan Revenue in Brain Disease Business (2014-2019)
12.8.5 Allergan Recent Development
12.9 Merck
12.9.1 Merck Company Details
12.9.2 Company Description and Business Overview
12.9.3 Brain Disease Introduction
12.9.4 Merck Revenue in Brain Disease Business (2014-2019)
12.9.5 Merck Recent Development
12.10 Novartis
12.10.1 Novartis Company Details
12.10.2 Company Description and Business Overview
12.10.3 Brain Disease Introduction
12.10.4 Novartis Revenue in Brain Disease Business (2014-2019)
12.10.5 Novartis Recent Development
12.11 AstraZeneca
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Brain Disease Key Market Segments
Table Key Players Brain Disease Covered
Table Global Brain Disease Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Brain Disease Market Size Market Share by Type 2014-2025
Figure Brain Cancer Figures
Table Key Players of Brain Cancer
Figure Alzheimer Disease Figures
Table Key Players of Alzheimer Disease
Figure Alcoholism Figures
Table Key Players of Alcoholism
Figure Amnesia Figures
Table Key Players of Amnesia
Figure Epilepsy Figures
Table Key Players of Epilepsy
Figure Meningitis Figures
Table Key Players of Meningitis
Figure Others Figures
Table Key Players of Others
Table Global Brain Disease Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Pharmacy Case Studies
Figure Online Pharmacy Case Studies
Figure Pharmacy Case Studies
Figure Brain Disease Report Years Considered
Table Global Brain Disease Market Size 2014-2025 (Million US$)
Figure Global Brain Disease Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Brain Disease Market Size by Regions 2014-2025 (Million US$)
Table Global Brain Disease Market Size by Regions 2014-2019 (Million US$)
Table Global Brain Disease Market Share by Regions 2014-2019
Figure Global Brain Disease Market Share by Regions 2014-2019
Figure Global Brain Disease Market Share by Regions 2019
Table Market Top Trends
Table Global Brain Disease Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Brain Disease Market Share by Manufacturers (2014-2019)
Figure Global Brain Disease Market Share by Manufacturers in 2018
Table Global Brain Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Brain Disease Product/Solution/Service
Table Date of Enter into Brain Disease Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Brain Disease Market Size by Type (2014-2019) (Million US$)
Table Global Brain Disease Market Size Share by Type (2014-2019)
Figure Global Brain Disease Market Size Market Share by Type (2014-2019)
Table Global Brain Disease Market Size by Application (2014-2019) (Million US$)
Table Global Brain Disease Market Size Share by Application (2014-2019)
Figure Global Brain Disease Market Size Market Share by Application (2014-2019)
Figure Global Brain Disease Revenue Market Share by Application in 2018
Figure United States Brain Disease Market Size 2014-2019 (Million US$)
Table United States Key Players Brain Disease Revenue (2018-2019) (Million US$)
Table United States Key Players Brain Disease Market Share (2018-2019)
Table United States Brain Disease Market Size by Type (2014-2019) (Million US$)
Table United States Brain Disease Market Share by Type (2014-2019)
Table United States Brain Disease Market Size by Application (2014-2019) (Million US$)
Table United States Brain Disease Market Share by Application (2014-2019)
Figure Europe Brain Disease Market Size 2014-2019 (Million US$)
Table Europe Key Players Brain Disease Revenue (2018-2019) (Million US$)
Table Europe Key Players Brain Disease Market Share (2018-2019)
Table Europe Brain Disease Market Size by Type (2014-2019) (Million US$)
Table Europe Brain Disease Market Share by Type (2014-2019)
Table Europe Brain Disease Market Size by Application (2014-2019) (Million US$)
Table Europe Brain Disease Market Share by Application (2014-2019)
Figure China Brain Disease Market Size 2014-2019 (Million US$)
Table China Key Players Brain Disease Revenue (2018-2019) (Million US$)
Table China Key Players Brain Disease Market Share (2018-2019)
Table China Brain Disease Market Size by Type (2014-20189) (Million US$)
Table China Brain Disease Market Share by Type (2014-2019)
Table China Brain Disease Market Size by Application (2014-2019) (Million US$)
Table China Brain Disease Market Share by Application (2014-2019)
Figure Japan Brain Disease Market Size 2014-2019 (Million US$)
Table Japan Key Players Brain Disease Revenue (2018-2019) (Million US$)
Table Japan Key Players Brain Disease Market Share (2018-2019)
Table Japan Brain Disease Market Size by Type (2014-2019) (Million US$)
Table Japan Brain Disease Market Share by Type (2014-2019)
Table Japan Brain Disease Market Size by Application (2014-2019) (Million US$)
Table Japan Brain Disease Market Share by Application (2014-2019)
Figure Southeast Asia Brain Disease Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Brain Disease Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Brain Disease Market Share (2018-2019)
Table Southeast Asia Brain Disease Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Brain Disease Market Share by Type (2014-2019)
Table Southeast Asia Brain Disease Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Brain Disease Market Share by Application (2014-2019)
Figure India Brain Disease Market Size 2014-2019 (Million US$)
Table India Key Players Brain Disease Revenue (2018-2019) (Million US$)
Table India Key Players Brain Disease Market Share (2018-2019)
Table India Brain Disease Market Size by Type (2014-2019) (Million US$)
Table India Brain Disease Market Share by Type (2014-2019)
Table India Brain Disease Market Size by Application (2014-2019) (Million US$)
Table India Brain Disease Market Share by Application (2014-2019)
Figure Central & South America Brain Disease Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Brain Disease Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Brain Disease Market Share (2018-2019)
Table Central & South America Brain Disease Market Size by Type (2014-2019) (Million US$)
Table Central & South America Brain Disease Market Share by Type (2014-2019)
Table Central & South America Brain Disease Market Size by Application (2014-2019) (Million US$)
Table Central & South America Brain Disease Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Brain Disease Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Brain Disease Business (2014-2019)
Table Pfizer Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Brain Disease Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Brain Disease Business (2014-2019)
Table Eli Lilly Recent Development
Table F. Hoffmann La Roche Company Details
Table F. Hoffmann La Roche Revenue in Brain Disease Business (2014-2019)(Million US$)
Figure F. Hoffmann La Roche Revenue Growth Rate in Brain Disease Business (2014-2019)
Table F. Hoffmann La Roche Recent Development
Table GE Healthcare Company Details
Table GE Healthcare Revenue in Brain Disease Business (2014-2019)(Million US$)
Figure GE Healthcare Revenue Growth Rate in Brain Disease Business (2014-2019)
Table GE Healthcare Recent Development
Table Janssen Pharmaceuticals Company Details
Table Janssen Pharmaceuticals Revenue in Brain Disease Business (2014-2019)(Million US$)
Figure Janssen Pharmaceuticals Revenue Growth Rate in Brain Disease Business (2014-2019)
Table Janssen Pharmaceuticals Recent Development
Table Abbvie Company Details
Table Abbvie Revenue in Brain Disease Business (2014-2019)(Million US$)
Figure Abbvie Revenue Growth Rate in Brain Disease Business (2014-2019)
Table Abbvie Recent Development
Table AC Immune Company Details
Table AC Immune Revenue in Brain Disease Business (2014-2019)(Million US$)
Figure AC Immune Revenue Growth Rate in Brain Disease Business (2014-2019)
Table AC Immune Recent Development
Table Allergan Company Details
Table Allergan Revenue in Brain Disease Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Brain Disease Business (2014-2019)
Table Allergan Recent Development
Table Merck Company Details
Table Merck Revenue in Brain Disease Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Brain Disease Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Brain Disease Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Brain Disease Business (2014-2019)
Table Novartis Recent Development
Table AstraZeneca Company Details
Table Global Brain Disease Market Size by Regions (Million US$) 2019-2025
Figure Global Brain Disease Market Size Share by Regions (2019-2025)
Figure Global Brain Disease Market Size Share by Regions in 2025
Figure United States Brain Disease Market Size Forecast (2019-2025)(Million USD)
Figure Europe Brain Disease Market Size Forecast (2019-2025)(Million USD)
Figure China Brain Disease Market Size Forecast (2019-2025)(Million USD)
Figure Japan Brain Disease Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Brain Disease Market Size Forecast (2019-2025)(Million USD)
Figure India Brain Disease Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Brain Disease Market Size Forecast (2019-2025)(Million USD)
Table Global Brain Disease Market Size by Product (2019-2025) (Million US$)
Figure Global Brain Disease Market Size by Product (2019-2025)
Figure Global Brain Disease Market Size by Product in 2025
Table Global Brain Disease Market Size by Application (2019-2025) (Million US$)
Figure Global Brain Disease Market Size by Application (2019-2025)
Figure Global Brain Disease Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
脳インプラントの世界市場：インサイト・予測 Brain implants, often referred to as neural implants, are technological devices that connect directly to a biological subject's brain – usually placed on the surface of the brain, or attached to the brain's cortex.In 2017, the deep brain stimulator segment was identified as the largest. The product …- 脳波指紋技術の世界市場：市場規模・現状・予測 Brain Fingerprinting Technology is a computer based technology designed to determine hidden information in individual's brain by measuring electrical brain wave responses to words, phrases, or pictures presented on a computer screen. In 2018, the global Brain Fingerprinting Technology market size wa…
- 脳波指紋技術の世界市場：市場規模・現状・予測 Brain Fingerprinting Technology is a computer based technology designed to determine hidden information in individual's brain by measuring electrical brain wave responses to words, phrases, or pictures presented on a computer screen. In 2018, the global Brain Fingerprinting Technology market size wa…
- 脳卒中の世界市場：市場規模・現状・予測 Brain Stroke is one of the most common types of neurovascular disease in which either a clot blocks restricts supply of blood to the brain (ischemic) or blood vessels in the brain rupture (hemorrhagic). The vascular diseases affect normal functioning of the veins and arteries that constitute circula…
- パーキンソン病治療の世界市場：市場規模・現状・予測 Parkinson’s disease (PD) is a chronic and progressive disease, considered an idiopathic form, and accounts for roughly 80% of the cases of Parkinsonism—neurological disorders that lead to movement problems. While the exact cause of Parkinson’s disease is unknown, it may include a number of factors s…